Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a severe lung disease occurring throughout the world; however, few clinical therapies are available for treating this disorder. Overactivated fibroblasts drive abnormal fibrosis accumulation to maintain dynamic balance between inflammation and extracellular matrix (ECM) stiffness. Given pulmonary cell can regenerate, the lung may possess self-repairing abilities if fibrosis is removed via clearance of overactivated fibroblasts. The aim of this study was to evaluate the therapeutic activity of transient antifibrotic chimeric antigen receptor (CAR) T cells (generated via a novelly-designed lipid nanoparticle-messenger RNA (LNP-mRNA) system) and explore the regeneration mechanisms of lung in a male mouse model of bleomycin-induced pulmonary fibrosis. Here we found that fibrosis-induced ECM stiffening impaired alveolar epithelial cell compensation. The proposed LNP-mRNA therapy eliminated overactivated fibroblasts to rescue pulmonary fibrosis. The restored ECM environment regulated the cellular profile. The elevated plasticity of AT2 and Pclaf+ cells increased AT1 cell population via polarization. Apoe+ macrophages and increased numbers of effector T cells were shown to reestablish pulmonary immunity. Hence, LNP-mRNA treatment for fibrosis can restore pulmonary structure and function to similar degrees to those of a healthy lung. This therapy is a potential treatment for IPF patients. Pulmonary fibrosis is a severe lung disease with limited clinical therapies. Here the authors show that chimeric antigen receptor cells can rescue pulmonary fibrosis in a mouse model, and they further investigate the mechanism of lung regeneration after treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CAR-T cells designed to recognize fibroblast activation protein (FAP) on pathogenic fibroblasts and engineered to modulate mechanical signal transduction pathways may achieve selective clearance of fibrogenic cells while adapting to the altered mechanical microenvironment (162, 163).”
From The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives (2025) · doi:10.3389/fimmu.2025.1670213 · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Effects of extracellular matrix viscoelasticity on cellular behaviour
Chaudhuri, O., Cooper-White, J., Janmey, P. A., Mooney, D. J., & Shenoy, V. B. (2020) · Nature · doi:10.1038/s41586-020-2612-2 · Cited by 2,224 · cited 1×
“Cell membrane receptors transmit the change of pathological signals into epithelial cells to cause cascade reactions while integrin-based adhesions translate mechanical signals to affect actin aggregation and movement 52 – 54 .”
Mechanotransduction and extracellular matrix homeostasis
Humphrey, J. D., Dufresne, E. R., & Schwartz, M. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3896 · Cited by 2,124
Richeldi, L., Collard, H. R., & Jones, M. G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30866-8 · Cited by 2,020
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868 · cited 2×
“Compared with traditionaldrugs that blocksignaling pathways 8 , chimericantigen receptor (CAR)-”
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft, T., Simpson, J. M., & Timbrell, V (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,680
SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness
Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2622-0 · Cited by 1,615 · cited 1×
“The ex vivo synthesized sequences of FAPCAR were cloned into IVT template plasmid as the ORF region which also carried T7 promoter, modi fi ed 5 ’ UTR, kozak sequence, 3 ’ UTR, and a 110 nt-long poly (A) tail 59 – 61 .”
Pan-cancer single-cell landscape of tumor-infiltrating T cells
Zheng, L., Qin, S., Si, W., Wang, A., Xing, B., Gao, R., Ren, X., Wang, L., Wu, X., Zhang, J., et al. (2021) · Science · doi:10.1126/science.abe6474 · Cited by 1,402
Research works printed but not linked: 1
- Yoon, H. Y., Kim, H., Bae, Y. & Song, J. W. Pirfenidone and risk of lung cancer development in IPF: a nationwide population-based study. Eur. Respir. J. 7, 2401484 (2024).
Cited by
Targeting persistently activated inflammatory microenvironment to promote chronic wound healing
Dai, Y., & Chen, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1708358 · Cited by 47
(2025) · doi:10.3389/fimmu.2025.1670213 · Cited by 29
“CAR-T cells designed to recognize fi broblast activation protein (FAP) on pathogenic fi broblasts and engineered to modulate mechanical signal transduction pathways may achieve selective clearance of fi brogenic cells while adapting to the altered mechanical microenvironment (162, 163).”
CAR-engineered cell therapies: current understandings and future perspectives
Bayat, M., & Nahand, J. S. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00401-4 · Cited by 37
In vivo CAR cell therapy: from bench to bedside
Jia, X., Chen, Z., Su, L., Ren, A., & Mei, H. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01759-2 · Cited by 35
Yang, H., Yu, X., Guo, Z., Shi, S., Wang, J., Guo, S., Hu, B., Chai, M., Wang, Z., Barth, S., et al. (2025) · Cyborg and Bionic Systems · doi:10.34133/cbsystems.0436 · Cited by 19
“Compared with current mainstream siRNA delivery systems, such as lipid nanoparticles (LNPs) [ 34 , 35 ], polymer-based carriers [ 36 ], and GalNAc conjugation technology [ 37 ], the PDR system demonstrates significant advantages in achieving precise delivery to the target site.”
Metadata
- Authors
- Yan, J., Wang, S.-Y., Su, Q., Zou, M.-W., Zhou, Z.-Y., Shou, J., & Huo, Y.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Huo, Yunlong
- Venue
- Nature Communications
- Published
- 2025-04-21
- Volume
- 16
- Issue
- 1
- Pages
- 3748-3748
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC12012202
- OpenAlex
- W4409640311
- Cited by
- 62
- References
- 65
- Citations by year
- 2026: 44 · 2025: 18
- FWCI
- 40.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Key Research and Development Program of China (KQTD20180411143400981, 2021YFA1000203)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, chimeric antigen receptor T cells, activated fibroblasts, extracellular matrix stiffness, alveolar type II cells, alveolar type I cells, macrophage polarization, lung regeneration, bleomycin-induced fibrosis, lung immunity
- MeSH terms
- Animals, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Humans, Immunotherapy, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, RNA, Messenger, T-Lymphocytes, Mice, Nanoparticles, Idiopathic Pulmonary Fibrosis, Alveolar Epithelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile. https://app.cochat.ai/papers/10.1038/s41467-025-59093-7
- The paper
- Yan, J., Wang, S.-Y., Su, Q., Zou, M.-W., Zhou, Z.-Y., Shou, J., & Huo, Y. (2025). Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile. Nature Communications. https://doi.org/10.1038/s41467-025-59093-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.